Biglycan-deficient mice have delayed osteogenesis after marrow ablation

X. D. Chen, Matthew Allen, S. Bloomfield, T. Xu, M. Young

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Biglycan (bgn) is a small proteoglycan in skeletal tissue that binds and regulates collagen and TGF-beta activities. Mice deficient in bgn (bgn-KO) develop age-dependent osteopenia and have multiple metabolic defects in their bone marrow stromal cells including increased apoptosis, reduced numbers of colony-forming units-fibroblastic (CFU-F) and decreased collagen production. In the present study we tested the hypothesis that bone formation capability in response to a physiological stress is compromised in bgn deficiency. We tested this theory using an in vivo bone marrow ablation assay. Ablation was performed on 6-week-old wild type (wt) and bgn-KO mice and bones were analyzed at days 7, 10, and 17 postsurgery. X-ray analysis showed that bone marrow ablation in femora induced vigorous new bone formation within 10 days in both genotypes but appeared greater in the wt compared to the bgn-KO. In order to quantitate the changes in bone formation in the ablated animals, bone densities of the proximal, midshaft, and distal femora were assessed using peripheral quantitative computed tomography (pQCT). The ratio of cancellous bone density at the midshaft (ablated limb/control limb) was significantly higher in wt compared to bgn-KO at day 10 postsurgery. Wt and bgn-KO femora had similar total and cancellous bone densities at days 7 and 17 postsurgery at all three locations indicating that the ablation effects were temporal and limited to the cancellous bone of the mid-shaft region. These data indicate that the absence of bgn directly impeded bone formation. Our results support the concept that bgn is important in controlling osteogenesis following marrow ablation.

Original languageEnglish (US)
Pages (from-to)577-582
Number of pages6
JournalCalcified Tissue International
Volume72
Issue number5
DOIs
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Biglycan
Osteogenesis
Bone Marrow
Bone Density
Femur
Collagen
Extremities
Physiological Stress
Metabolic Bone Diseases
Proteoglycans
Mesenchymal Stromal Cells
Transforming Growth Factor beta
Stem Cells
Genotype
Tomography

Keywords

  • Biglycan
  • Bone formation
  • Bone repair
  • Marrow ablation

ASJC Scopus subject areas

  • Endocrinology

Cite this

Biglycan-deficient mice have delayed osteogenesis after marrow ablation. / Chen, X. D.; Allen, Matthew; Bloomfield, S.; Xu, T.; Young, M.

In: Calcified Tissue International, Vol. 72, No. 5, 01.05.2003, p. 577-582.

Research output: Contribution to journalArticle

Chen, X. D. ; Allen, Matthew ; Bloomfield, S. ; Xu, T. ; Young, M. / Biglycan-deficient mice have delayed osteogenesis after marrow ablation. In: Calcified Tissue International. 2003 ; Vol. 72, No. 5. pp. 577-582.
@article{6067d75c5a0441db86639804305a2c0c,
title = "Biglycan-deficient mice have delayed osteogenesis after marrow ablation",
abstract = "Biglycan (bgn) is a small proteoglycan in skeletal tissue that binds and regulates collagen and TGF-beta activities. Mice deficient in bgn (bgn-KO) develop age-dependent osteopenia and have multiple metabolic defects in their bone marrow stromal cells including increased apoptosis, reduced numbers of colony-forming units-fibroblastic (CFU-F) and decreased collagen production. In the present study we tested the hypothesis that bone formation capability in response to a physiological stress is compromised in bgn deficiency. We tested this theory using an in vivo bone marrow ablation assay. Ablation was performed on 6-week-old wild type (wt) and bgn-KO mice and bones were analyzed at days 7, 10, and 17 postsurgery. X-ray analysis showed that bone marrow ablation in femora induced vigorous new bone formation within 10 days in both genotypes but appeared greater in the wt compared to the bgn-KO. In order to quantitate the changes in bone formation in the ablated animals, bone densities of the proximal, midshaft, and distal femora were assessed using peripheral quantitative computed tomography (pQCT). The ratio of cancellous bone density at the midshaft (ablated limb/control limb) was significantly higher in wt compared to bgn-KO at day 10 postsurgery. Wt and bgn-KO femora had similar total and cancellous bone densities at days 7 and 17 postsurgery at all three locations indicating that the ablation effects were temporal and limited to the cancellous bone of the mid-shaft region. These data indicate that the absence of bgn directly impeded bone formation. Our results support the concept that bgn is important in controlling osteogenesis following marrow ablation.",
keywords = "Biglycan, Bone formation, Bone repair, Marrow ablation",
author = "Chen, {X. D.} and Matthew Allen and S. Bloomfield and T. Xu and M. Young",
year = "2003",
month = "5",
day = "1",
doi = "10.1007/s00223-002-1101-y",
language = "English (US)",
volume = "72",
pages = "577--582",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Biglycan-deficient mice have delayed osteogenesis after marrow ablation

AU - Chen, X. D.

AU - Allen, Matthew

AU - Bloomfield, S.

AU - Xu, T.

AU - Young, M.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Biglycan (bgn) is a small proteoglycan in skeletal tissue that binds and regulates collagen and TGF-beta activities. Mice deficient in bgn (bgn-KO) develop age-dependent osteopenia and have multiple metabolic defects in their bone marrow stromal cells including increased apoptosis, reduced numbers of colony-forming units-fibroblastic (CFU-F) and decreased collagen production. In the present study we tested the hypothesis that bone formation capability in response to a physiological stress is compromised in bgn deficiency. We tested this theory using an in vivo bone marrow ablation assay. Ablation was performed on 6-week-old wild type (wt) and bgn-KO mice and bones were analyzed at days 7, 10, and 17 postsurgery. X-ray analysis showed that bone marrow ablation in femora induced vigorous new bone formation within 10 days in both genotypes but appeared greater in the wt compared to the bgn-KO. In order to quantitate the changes in bone formation in the ablated animals, bone densities of the proximal, midshaft, and distal femora were assessed using peripheral quantitative computed tomography (pQCT). The ratio of cancellous bone density at the midshaft (ablated limb/control limb) was significantly higher in wt compared to bgn-KO at day 10 postsurgery. Wt and bgn-KO femora had similar total and cancellous bone densities at days 7 and 17 postsurgery at all three locations indicating that the ablation effects were temporal and limited to the cancellous bone of the mid-shaft region. These data indicate that the absence of bgn directly impeded bone formation. Our results support the concept that bgn is important in controlling osteogenesis following marrow ablation.

AB - Biglycan (bgn) is a small proteoglycan in skeletal tissue that binds and regulates collagen and TGF-beta activities. Mice deficient in bgn (bgn-KO) develop age-dependent osteopenia and have multiple metabolic defects in their bone marrow stromal cells including increased apoptosis, reduced numbers of colony-forming units-fibroblastic (CFU-F) and decreased collagen production. In the present study we tested the hypothesis that bone formation capability in response to a physiological stress is compromised in bgn deficiency. We tested this theory using an in vivo bone marrow ablation assay. Ablation was performed on 6-week-old wild type (wt) and bgn-KO mice and bones were analyzed at days 7, 10, and 17 postsurgery. X-ray analysis showed that bone marrow ablation in femora induced vigorous new bone formation within 10 days in both genotypes but appeared greater in the wt compared to the bgn-KO. In order to quantitate the changes in bone formation in the ablated animals, bone densities of the proximal, midshaft, and distal femora were assessed using peripheral quantitative computed tomography (pQCT). The ratio of cancellous bone density at the midshaft (ablated limb/control limb) was significantly higher in wt compared to bgn-KO at day 10 postsurgery. Wt and bgn-KO femora had similar total and cancellous bone densities at days 7 and 17 postsurgery at all three locations indicating that the ablation effects were temporal and limited to the cancellous bone of the mid-shaft region. These data indicate that the absence of bgn directly impeded bone formation. Our results support the concept that bgn is important in controlling osteogenesis following marrow ablation.

KW - Biglycan

KW - Bone formation

KW - Bone repair

KW - Marrow ablation

UR - http://www.scopus.com/inward/record.url?scp=0043160417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043160417&partnerID=8YFLogxK

U2 - 10.1007/s00223-002-1101-y

DO - 10.1007/s00223-002-1101-y

M3 - Article

VL - 72

SP - 577

EP - 582

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 5

ER -